Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « against »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
after < against < againstplasmodium  Facettes :

List of bibliographic references indexed by against

Number of relevant bibliographic references: 69.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000000 (2020-03) Christian Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France]New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
000027 (2020) Sarah D Lessandro ; Diletta Scaccabarozzi ; Lucia Signorini ; Federica Perego ; Denise P. Ilboudo ; Pasquale Ferrante ; Serena DelbueThe Use of Antimalarial Drugs against Viral Infection
000224 (2020) Alaa Riezk [Royaume-Uni] ; John G. Raynes [Royaume-Uni] ; Vanessa Yardley [Royaume-Uni] ; Sudaxshina Murdan [Royaume-Uni] ; Simon L. Croft [Royaume-Uni]Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicanaIn Vitro
000234 (2020) Houshuang Zhang ; Zhonghua Wang ; Jingwei Huang ; Jie Cao ; Yongzhi Zhou ; Jinlin ZhouA Novel Thioredoxin-Dependent Peroxiredoxin (TPx-Q) Plays an Important Role in Defense Against Oxidative Stress and Is a Possible Drug Target in Babesia microti
000267 (2019) Meilin Wang ; Jingling Niu ; Lina Ou ; Bo Deng ; Yingyi Wang ; Sanqiang LiZerumbone Protects against Carbon Tetrachloride (CCl4)-Induced Acute Liver Injury in Mice via Inhibiting Oxidative Stress and the Inflammatory Response: Involving the TLR4/NF-κB/COX-2 Pathway
000279 (2019) Dong Liang [République populaire de Chine] ; Hong-Ying Wang [République populaire de Chine] ; Shu Fan [République populaire de Chine] ; Jin Wang [République populaire de Chine] ; Ying Shen [République populaire de Chine] ; Chen-Ying Gao [République populaire de Chine] ; Man-Li Wu [République populaire de Chine] ; She-Min Lu [République populaire de Chine] ; San-Qi Zhang [République populaire de Chine] ; Wei Han [Suède]W941, a new PI3K inhibitor, exhibits preferable anti-proliferative activities against nonsmall cell lung cancer with autophagy inhibitors.
000304 (2019) Rana Jahanban-Esfahlan [Iran] ; Khaled Seidi [Iran] ; Masoud H. Manjili [États-Unis] ; Ali Jahanban-Esfahlan [Iran] ; Tahereh Javaheri [Autriche] ; Peyman Zare [Pologne]Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
000422 (2019) Khalid Hussain Wali Sait ; Qamre Alam ; Nisrin Anfinan [Arabie saoudite] ; Othman Al-Ghamdi ; Arshi Malik [Arabie saoudite] ; Rana Noor [Inde] ; Farheen Jahan [Inde] ; Mohammed Tarique [Inde]Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer
000464 (2019) Liang Kang [République populaire de Chine] ; Qian Xiang [République populaire de Chine] ; Shengfeng Zhan [République populaire de Chine] ; Yu Song [République populaire de Chine] ; Kun Wang [République populaire de Chine] ; Kangcheng Zhao [République populaire de Chine] ; Shuai Li [République populaire de Chine] ; Zengwu Shao [République populaire de Chine] ; Cao Yang [République populaire de Chine] ; Yukun Zhang [République populaire de Chine]Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration
000466 (2019) Thomas R. Lane [États-Unis] ; Jason E. Comer [États-Unis] ; Alexander N. Freiberg [États-Unis] ; Peter B. Madrid [États-Unis] ; Sean Ekins [États-Unis]Repurposing Quinacrine against Ebola Virus Infection In Vivo
000541 (2019) Gisele Bulh Es Portapilla [Brésil] ; Luiz Miguel Pereira [Brésil] ; Cássia Mariana Bronzon Da Costa [Brésil] ; Maiara Voltarelli Providello [Brésil] ; Pedro Alexandre Sampaio Oliveira [Brésil] ; Amanda Goulart [Brésil] ; Naira Ferreira Anchieta [Brésil] ; Mark Wainwright [Royaume-Uni] ; Gilberto Bida Leite Braga [Brésil] ; Sérgio De Albuquerque [Brésil]Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro
000577 (2019) Martin Michaelis [Royaume-Uni] ; Malte C. Kleinschmidt [Allemagne] ; Denisa Bojkova [Allemagne] ; Holger F. Rabenau [Allemagne] ; Mark N. Wass [Royaume-Uni] ; Jindrich Cinatl Jr. [Allemagne]Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
000581 (2019) Sangita Sridharan [États-Unis] ; Cory M. Howard [États-Unis] ; Augustus M. C. Tilley [États-Unis] ; Boopathi Subramaniyan [États-Unis] ; Amit K. Tiwari [États-Unis] ; Randall J. Ruch [États-Unis] ; Dayanidhi Raman [États-Unis]Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
000704 (2019) Naveed Sabir ; Tariq Hussain ; Yi Liao ; Jie Wang ; Yinjuan Song ; Muhammad Shahid ; Guangyu Cheng ; Mazhar Hussain Mangi ; Jiao Yao ; Lifeng Yang ; Deming Zhao ; Xiangmei ZhouKallikrein 12 Regulates Innate Resistance of Murine Macrophages against Mycobacterium bovis Infection by Modulating Autophagy and Apoptosis
000753 (2019) Roos M. De Jong ; Surafel K. Tebeje ; Lisette Meerstein-Kessel ; Fitsum G. Tadesse ; Matthijs M. Jore ; Will Stone ; Teun BousemaImmunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
000755 (2019) Carla Proietti [Australie] ; Lutz Krause [Australie] ; Angela Trieu [Australie] ; Daniel Dodoo [Ghana] ; Ben Gyan [Ghana] ; Kwadwo A. Koram [Ghana] ; William O. Rogers ; Thomas L. Richie ; Peter D. Crompton [États-Unis] ; Philip L. Felgner [États-Unis] ; Denise L. Doolan [Australie]Immune Signature Against Plasmodium falciparum Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities*
000758 (2019) Lu Zhang [République populaire de Chine] ; Pengfei Qiang [République populaire de Chine] ; Jingting Yu [République populaire de Chine] ; Yiming Miao [République populaire de Chine] ; Zhiqiang Chen [République populaire de Chine] ; Ju Qu [République populaire de Chine] ; Qianbing Zhao [République populaire de Chine] ; Zhuo Chen [République populaire de Chine] ; Yachao Liu [République populaire de Chine] ; Xin Yao [République populaire de Chine] ; Bin Liu [République populaire de Chine] ; Liuqing Cui [République populaire de Chine] ; Hongjuan Jing [République populaire de Chine] ; Gangchun Sun [République populaire de Chine]Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
000796 (2019) Haiyan Liang [République populaire de Chine] ; Suwei Zhang [République populaire de Chine] ; Zhiling Li [République populaire de Chine]Ginsenoside Rg3 protects mouse leydig cells against triptolide by downregulation of miR-26a
000830 (2019) Asmaa M. El-Kady ; Alzahraa Abdelraouf Ahmad [Égypte] ; Tasneem M. Hassan [Égypte] ; Heba E M. El-Deek [Égypte] ; Samer S. Fouad [Égypte] ; Sultan S. Althagfan [Arabie saoudite]Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against Schistosoma mansoni, induced liver pathology
000844 (2019) Tao-Tao Tang [République populaire de Chine] ; Lin-Li Lv [République populaire de Chine] ; Bin Wang [République populaire de Chine] ; Jing-Yuan Cao [République populaire de Chine] ; Ye Feng [République populaire de Chine] ; Zuo-Lin Li [République populaire de Chine] ; Min Wu [République populaire de Chine] ; Feng-Mei Wang [République populaire de Chine] ; Yi Wen [République populaire de Chine] ; Le-Ting Zhou [République populaire de Chine] ; Hai-Feng Ni [République populaire de Chine] ; Ping-Sheng Chen [République populaire de Chine] ; Ning Gu [République populaire de Chine] ; Steven D. Crowley [États-Unis] ; Bi-Cheng LiuEmploying Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis
000852 (2019) Peter C. Taylor ; Didier Saurigny [Royaume-Uni] ; Jiri Vencovsky [République tchèque] ; Tsutomu Takeuchi [Japon] ; Tadashi Nakamura [Japon] ; Galina Matsievskaia [Russie] ; Barbara Hunt [États-Unis] ; Thomas Wagner [Suisse] ; Bernard Souberbielle [Royaume-Uni]Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "against" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "against" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    against
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021